cGxP.wire https://validator.w3.org/feed/docs/rss2.html Regeneron Wins FDA Approval for Pasatru in FOP Akeso Advances AK157D1 B7-H3 ADC Into Phase I Implantica Wins FDA Approval for RefluxStop® in U.S. C2N PrecivityAD2 FDA Clearance Advances Alzheimer’s Testing Dizal to Present ZEGFROVY NSCLC Data at WCLC 2026 Leads Biolabs Advances Opamtistomig Toward Approval Chai Discovery and BMS Advance AI Antibody Discovery Raintree Expands Agentic AI for Rehab Therapy Vascarta Begins Phase I Study of VAS-101 in SCD Keenova Begins Phase 3 XIAFLEX Trial for Hammer Toe Alzamend Neuro Shares Lithium Imaging Data at Neuroscience 2026 IceCure Advances Breast Cancer Cryoablation Study FibroBiologics Gains Australian Patent for Disc Therapy Galvanize Therapeutics Reports New Immune Activity Data Maverix Medical Advances Lung Cancer Diagnosis With Narwhal Revance Wins FDA Approval for RHA Redensity Eye Filler RenovoRx Expands RenovoCath Patent Protection for Cancer Ipsen Completes Kartos Acquisition to Expand Oncology Pipeline Telix Strengthens Radiopharmaceutical Pipeline with Multiple Late-Stage Clinical Milestones Hyperfine Gains FDA Clearance for Next Optive AI Software Superbrewed Food Launches Shelf-Stable Thryvia Postbiotic Charles River and Medigen Advance Vaccine Development With NGS Turn Therapeutics Reports GX-03 Skin Inflammation Research Allure Beauty Concepts Expands OTC Manufacturing iECURE to Present ECUR-506 Clinical Data in OTC Deficiency Zeon Lifesciences Advances U.S. Nutraceutical Readiness VarmX Starts Phase 3 Trial of VMX-C001 in Urgent Surgery Subtle Medical Expands AI Imaging Leadership With Tanenbaum Rein Therapeutics Gains FDA Fast Track for LTI-03 in IPF Nuvation Bio Gains FDA Fast Track for Safusidenib Akiram Therapeutics and ITM Sign Lutetium-177 Supply Agreement to Advance AKIR001 in Solid Tumors FDA Authorizes Aletta Robotic Blood Draw Device Ultragenyx Wins FDA Approval for GENGLYCOS Gene Therapy Ionis and AstraZeneca Showcase Cardiovascular Pipeline Progress with New Data at ESC Congress 2026 Tolerance Bio Licenses Long-Acting IL-7 Therapy Lupin Expands Europe Access to YUVEZZI Presbyopia Therapy UroGen Expands Oncology Pipeline Through IntraGel Deal HealthTab and Abbott Expand UK Point-of-Care Testing FDA Seeks Input on Generative AI Medical Device Rules Harrow Reports 58% Reduction in Patient-Reported Discomfort with IHEEZO® AC Immune Advances NLRP3 Inhibitor ACI-19764 in Phase 1 Johnson & Johnson Defines Future of Surgical Intelligence NTx Bio Advances Personalized Cancer Vaccine Manufacturing Teva’s Ecopipam NDA Wins FDA Priority Review Biodexa Advances Serenta Phase 3 Trial in FAP Arcato Reports Phase 1 Results for ARC-001 Gel ZEISS CLINIC 360 Gains FDA Clearance for Eye Care Sitero Expands Clinical AI Across the Data Lifecycle Andelyn Biosciences Moves Forward With AAV9-GM2 Gene Therapy BioNTech Advances Lung Cancer Pipeline Ahead of WCLC 2026